Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP957159.RAjec1dJVb_W9Ngf9EH1XiKLl2y-ateFIMHDv9NcKC-L0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP957159.RAjec1dJVb_W9Ngf9EH1XiKLl2y-ateFIMHDv9NcKC-L0130_assertion type Assertion NP957159.RAjec1dJVb_W9Ngf9EH1XiKLl2y-ateFIMHDv9NcKC-L0130_head.
- NP957159.RAjec1dJVb_W9Ngf9EH1XiKLl2y-ateFIMHDv9NcKC-L0130_assertion description "[Expression of TSP-1 and TSP-2 was detected in 33 (60.0%) and 15 cases (27.3%), respectively, of 55 endometrial cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957159.RAjec1dJVb_W9Ngf9EH1XiKLl2y-ateFIMHDv9NcKC-L0130_provenance.
- NP957159.RAjec1dJVb_W9Ngf9EH1XiKLl2y-ateFIMHDv9NcKC-L0130_assertion evidence source_evidence_literature NP957159.RAjec1dJVb_W9Ngf9EH1XiKLl2y-ateFIMHDv9NcKC-L0130_provenance.
- NP957159.RAjec1dJVb_W9Ngf9EH1XiKLl2y-ateFIMHDv9NcKC-L0130_assertion SIO_000772 11445843 NP957159.RAjec1dJVb_W9Ngf9EH1XiKLl2y-ateFIMHDv9NcKC-L0130_provenance.
- NP957159.RAjec1dJVb_W9Ngf9EH1XiKLl2y-ateFIMHDv9NcKC-L0130_assertion wasDerivedFrom befree-20150227 NP957159.RAjec1dJVb_W9Ngf9EH1XiKLl2y-ateFIMHDv9NcKC-L0130_provenance.
- NP957159.RAjec1dJVb_W9Ngf9EH1XiKLl2y-ateFIMHDv9NcKC-L0130_assertion wasGeneratedBy ECO_0000203 NP957159.RAjec1dJVb_W9Ngf9EH1XiKLl2y-ateFIMHDv9NcKC-L0130_provenance.